Clinical Trial Update: An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder [Phase 2]

View source ↗

Summary

An eight-week Phase 2 clinical trial evaluating treatment for major depressive disorder in adults has been completed, sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED